A Phase 3, Multicenter, Randomized, Double-blind, Active Comparator-controlled Study to Evaluate the Safety and Tolerability of V114 in Healthy Infants (PNEU-LINK)

Project: Other project

Project Details

StatusFinished
Effective start/end date11/29/1811/28/20

Funding

  • Merck Sharp & Dohme Corporation: $118,921.00